Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,816,648
  • Shares Outstanding, K 111,242
  • Annual Sales, $ 9,872 M
  • Annual Income, $ 871,000 K
  • EBIT $ 1,685 M
  • EBITDA $ 2,178 M
  • 60-Month Beta 0.64
  • Price/Sales 1.86
  • Price/Cash Flow 13.36
  • Price/Book 2.75

Options Overview Details

View History
  • Implied Volatility 24.18% (+0.17%)
  • Historical Volatility 19.81%
  • IV Percentile 77%
  • IV Rank 31.72%
  • IV High 39.40% on 04/11/25
  • IV Low 17.11% on 08/15/25
  • Expected Move (DTE 7) 4.83 (2.72%)
  • Put/Call Vol Ratio 25.16
  • Today's Volume 1,125
  • Volume Avg (30-Day) 589
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 9,788
  • Open Int (30-Day) 10,214
  • Expected Range 172.91 to 182.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.36
  • Number of Estimates 9
  • High Estimate 2.43
  • Low Estimate 2.32
  • Prior Year 2.23
  • Growth Rate Est. (year over year) +5.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
171.18 +3.84%
on 01/05/26
184.84 -3.84%
on 12/16/25
-4.08 (-2.24%)
since 12/08/25
3-Month
171.18 +3.84%
on 01/05/26
197.55 -10.03%
on 10/21/25
-3.15 (-1.74%)
since 10/08/25
52-Week
148.70 +19.53%
on 01/16/25
197.55 -10.03%
on 10/21/25
+23.71 (+15.39%)
since 01/08/25

Most Recent Stories

More News
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025

DGX : 177.74 (-0.22%)
EXAS : 101.78 (+0.15%)
ILMN : 145.83 (-2.87%)
ARVN : 12.18 (-1.85%)
PFE : 25.29 (+0.04%)
QTRX : 6.51 (-1.81%)
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

SECAUCUS, N.J. , Jan. 8, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full...

DGX : 177.74 (-0.22%)
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium

SECAUCUS, N.J. , Jan. 6, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that data will be shared on circulating tumor...

DGX : 177.74 (-0.22%)
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan

Quest also now provides comprehensive Collaborative Lab Solutions (Co-Lab) hospital lab management services for all 21 Corewell Health hospitals  

DGX : 177.74 (-0.22%)
What You Need To Know Ahead of Quest Diagnostics' Earnings Release

Quest Diagnostics is expected to unveil its fourth-quarter results soon, and analysts expect a single-digit growth in earnings.

ABT : 126.18 (-0.68%)
XLV : 158.12 (-0.96%)
DGX : 177.74 (-0.22%)
$SPX : 6,921.46 (+0.01%)
Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks

Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks

DGX : 177.74 (-0.22%)
How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks?

Despite Henry Schein’s underperformance relative to its peers, Wall Street analysts remain moderately optimistic about the stock’s prospects.

XLV : 158.12 (-0.96%)
HSIC : 79.00 (+1.10%)
DGX : 177.74 (-0.22%)
Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector?

Despite Bio-Techne’s weak performance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

TECH : 64.58 (-0.72%)
XLV : 158.12 (-0.96%)
DGX : 177.74 (-0.22%)
Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector?

Quest Diagnostics has outperformed the broader healthcare sector over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.

XLV : 158.12 (-0.96%)
DGX : 177.74 (-0.22%)
EXAS : 101.78 (+0.15%)
How Is Labcorp Holdings' Stock Performance Compared to Other Healthcare Stocks?

Despite Labcorp Holdings’ underperformance relative to its industry peers, Wall Street analysts remain strongly optimistic about the stock’s prospects.

XLV : 158.12 (-0.96%)
DGX : 177.74 (-0.22%)
LH : 254.67 (+0.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 183.99
2nd Resistance Point 182.33
1st Resistance Point 180.03
Last Price 177.74
1st Support Level 176.07
2nd Support Level 174.41
3rd Support Level 172.11

See More

52-Week High 197.55
Fibonacci 61.8% 178.89
Last Price 177.74
Fibonacci 50% 173.13
Fibonacci 38.2% 167.36
52-Week Low 148.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar